Oncolytics Biotech Investor Relations Material
Latest events
Q1 2025
Oncolytics Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oncolytics Biotech Inc
Access all reports
Oncolytics Biotech Inc is a biotechnology company developing immuno-oncology therapies to treat various cancers. The company focuses on the development of proprietary viral-based therapies that stimulate the immune system to target and destroy cancer cells. Oncolytics Biotech conducts clinical research and collaborates with pharmaceutical and academic partners. The company is headquartered in Calgary, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
ONCY
Country
🇺🇸 United States